These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
562 related articles for article (PubMed ID: 25775482)
1. Sex and Smoking Status Effects on the Early Detection of Early Lung Cancer in High-Risk Smokers Using an Electronic Nose. McWilliams A; Beigi P; Srinidhi A; Lam S; MacAulay CE IEEE Trans Biomed Eng; 2015 Aug; 62(8):2044-54. PubMed ID: 25775482 [TBL] [Abstract][Full Text] [Related]
2. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445 [TBL] [Abstract][Full Text] [Related]
3. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643 [TBL] [Abstract][Full Text] [Related]
4. Expiratory flow rate, breath hold and anatomic dead space influence electronic nose ability to detect lung cancer. Bikov A; Hernadi M; Korosi BZ; Kunos L; Zsamboki G; Sutto Z; Tarnoki AD; Tarnoki DL; Losonczy G; Horvath I BMC Pulm Med; 2014 Dec; 14():202. PubMed ID: 25510554 [TBL] [Abstract][Full Text] [Related]
5. Breath carbonyl compounds as biomarkers of lung cancer. Li M; Yang D; Brock G; Knipp RJ; Bousamra M; Nantz MH; Fu XA Lung Cancer; 2015 Oct; 90(1):92-7. PubMed ID: 26233567 [TBL] [Abstract][Full Text] [Related]
6. Volatile signature for the early diagnosis of lung cancer. Gasparri R; Santonico M; Valentini C; Sedda G; Borri A; Petrella F; Maisonneuve P; Pennazza G; D'Amico A; Di Natale C; Paolesse R; Spaggiari L J Breath Res; 2016 Feb; 10(1):016007. PubMed ID: 26857451 [TBL] [Abstract][Full Text] [Related]
7. Progress in the development of volatile exhaled breath signatures of lung cancer. Mazzone PJ; Wang XF; Lim S; Jett J; Choi H; Zhang Q; Beukemann M; Seeley M; Martino R; Rhodes P Ann Am Thorac Soc; 2015 May; 12(5):752-7. PubMed ID: 25965541 [TBL] [Abstract][Full Text] [Related]
8. Chromatographic analysis of VOC patterns in exhaled breath from smokers and nonsmokers. Capone S; Tufariello M; Forleo A; Longo V; Giampetruzzi L; Radogna AV; Casino F; Siciliano P Biomed Chromatogr; 2018 Apr; 32(4):. PubMed ID: 29131420 [TBL] [Abstract][Full Text] [Related]
9. Constructing an E-Nose Using Metal-Ion-Induced Assembly of Graphene Oxide for Diagnosis of Lung Cancer via Exhaled Breath. Chen Q; Chen Z; Liu D; He Z; Wu J ACS Appl Mater Interfaces; 2020 Apr; 12(15):17713-17724. PubMed ID: 32203649 [TBL] [Abstract][Full Text] [Related]
10. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines. Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150 [TBL] [Abstract][Full Text] [Related]
11. Exhaled biomarkers in lung cancer. Horváth I; Lázár Z; Gyulai N; Kollai M; Losonczy G Eur Respir J; 2009 Jul; 34(1):261-75. PubMed ID: 19567608 [TBL] [Abstract][Full Text] [Related]
12. Exhaled-breath Testing for Prostate Cancer Based on Volatile Organic Compound Profiling Using an Electronic Nose Device (Aeonose™): A Preliminary Report. Waltman CG; Marcelissen TAT; van Roermund JGH Eur Urol Focus; 2020 Nov; 6(6):1220-1225. PubMed ID: 30482583 [TBL] [Abstract][Full Text] [Related]
13. Association of Smoking with Metabolic Volatile Organic Compounds in Exhaled Breath. Chen X; Wang F; Lin L; Dong H; Huang F; Ghulam Muhammad K; Chen L; Gorlova OY Int J Mol Sci; 2017 Oct; 18(11):. PubMed ID: 29068415 [TBL] [Abstract][Full Text] [Related]
14. A breath test for malignant mesothelioma using an electronic nose. Chapman EA; Thomas PS; Stone E; Lewis C; Yates DH Eur Respir J; 2012 Aug; 40(2):448-54. PubMed ID: 22183490 [TBL] [Abstract][Full Text] [Related]
15. Rapid recognition of volatile organic compounds with colorimetric sensor arrays for lung cancer screening. Zhong X; Li D; Du W; Yan M; Wang Y; Huo D; Hou C Anal Bioanal Chem; 2018 Jun; 410(16):3671-3681. PubMed ID: 29654337 [TBL] [Abstract][Full Text] [Related]
16. Breathprinting and Early Diagnosis of Lung Cancer. Rocco G; Pennazza G; Santonico M; Longo F; Rocco R; Crucitti P; Antonelli Incalzi R J Thorac Oncol; 2018 Jul; 13(7):883-894. PubMed ID: 29526822 [TBL] [Abstract][Full Text] [Related]
17. Influence of age and gender on the profile of exhaled volatile organic compounds analyzed by an electronic nose. Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O J Bras Pneumol; 2016 Apr; 42(2):143-5. PubMed ID: 27167436 [TBL] [Abstract][Full Text] [Related]
18. BIONOTE e-nose technology may reduce false positives in lung cancer screening programmes†. Rocco R; Incalzi RA; Pennazza G; Santonico M; Pedone C; Bartoli IR; Vernile C; Mangiameli G; La Rocca A; De Luca G; Rocco G; Crucitti P Eur J Cardiothorac Surg; 2016 Apr; 49(4):1112-7; discussion 1117. PubMed ID: 26385981 [TBL] [Abstract][Full Text] [Related]
19. Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study. Poli D; Carbognani P; Corradi M; Goldoni M; Acampa O; Balbi B; Bianchi L; Rusca M; Mutti A Respir Res; 2005 Jul; 6(1):71. PubMed ID: 16018807 [TBL] [Abstract][Full Text] [Related]
20. Lack of heritability of exhaled volatile compound pattern: an electronic nose twin study. Tarnoki DL; Bikov A; Tarnoki AD; Lazar Z; Szilagyi BK; Korosi BZ; Horvath T; Littvay L; Losonczy G; Horvath I J Breath Res; 2014 Mar; 8(1):016001. PubMed ID: 24421262 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]